Thelial Technologies S.A. – Product Pipeline Review

Global Markets Direct’s, ‘Thelial Technologies S.A. – Product Pipeline Review – 2016’, provides an overview of the Thelial Technologies S.A.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Thelial Technologies S.A., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Thelial Technologies S.A.

The report provides overview of Thelial Technologies S.A. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Thelial Technologies S.A.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Thelial Technologies S.A.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Thelial Technologies S.A.’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Thelial Technologies S.A.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Thelial Technologies S.A.’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Thelial Technologies S.A. Snapshot 5

Thelial Technologies S.A. Overview 5

Key Information 5

Key Facts 5

Thelial Technologies S.A. - Research and Development Overview 6

Key Therapeutic Areas 6

Thelial Technologies S.A. - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Thelial Technologies S.A. - Pipeline Products Glance 10

Thelial Technologies S.A. - Early Stage Pipeline Products 10

Discovery Products/Combination Treatment Modalities 10

Thelial Technologies S.A. - Unknown Stage Pipeline Products 11

Unknown Products/Combination Treatment Modalities 11

Thelial Technologies S.A. - Drug Profiles 12

The-103 12

Product Description 12

Mechanism of Action 12

R&D Progress 12

The-104 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

The-105 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

The-106 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

The-107 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

The-108 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

The-109 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

The-110 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

The-111 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

The-124 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Thelial Technologies S.A. - Pipeline Analysis 22

Thelial Technologies S.A. - Pipeline Products by Route of Administration 22

Thelial Technologies S.A. - Pipeline Products by Molecule Type 23

Thelial Technologies S.A. - Locations And Subsidiaries 24

Head Office 24

Appendix 25

Methodology 25

Coverage 25

Secondary Research 25

Primary Research 25

Expert Panel Validation 25

Contact Us 25

Disclaimer 26

List of Tables

List of Tables

Thelial Technologies S.A., Key Information 5

Thelial Technologies S.A., Key Facts 5

Thelial Technologies S.A. – Pipeline by Indication, 2016 7

Thelial Technologies S.A. – Pipeline by Stage of Development, 2016 8

Thelial Technologies S.A. – Monotherapy Products in Pipeline, 2016 9

Thelial Technologies S.A. – Discovery, 2016 10

Thelial Technologies S.A. – Unknown, 2016 11

Thelial Technologies S.A. – Pipeline by Route of Administration, 2016 22

Thelial Technologies S.A. – Pipeline by Molecule Type, 2016 23

List of Figures

List of Figures

Thelial Technologies S.A. – Pipeline by Indication, 2016 7

Thelial Technologies S.A. – Pipeline by Stage of Development, 2016 8

Thelial Technologies S.A. – Monotherapy Products in Pipeline, 2016 9

Thelial Technologies S.A. – Pipeline by Molecule Type, 2016 23

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports